Author:
Russo Riccardo,Kolesnikova Irina,Kim Thomas,Gupta Shilpi,Pericleous Androulla,Kadouri Daniel,Connell Nancy
Abstract
Multi-drug resistant bacterial infections are a serious threat to global public health. Changes in treatment modalities and prudent use of antibiotics can assist in reducing the threat, but new approaches are also required for untreatable cases. The use of predatory bacteria, such as Bdellovibrio bacteriovorus, is among the novel approaches being considered as possible therapeutics for antibiotic resistant and/or unidentified bacterial infections. Previous studies have examined the feasibility of using predatory bacteria to reduce colony-forming units (CFUs) in the lungs of rats exposed to lethal doses of Klebsiella pneumoniae; here we apply the approach to the Tier 1 select agent Yersinia pestis, and show that three doses of B. bacteriovorus introduced every six hours reduces the number of CFUs of Y. pestis in the lungs of inoculated mice by 86% after 24 h of infection. These experiments further demonstrate that predatory bacteria may serve to combat Gram negative bacterial infections, including those considered potential bioweapon agents, in the future.
Funder
Defense Advanced Research Projects Agency
Subject
Virology,Microbiology (medical),Microbiology
Reference35 articles.
1. United Nations High-Level Meeting on Antimicrobial Resistancehttp://www.who.int/antimicrobial-resistance/events/UNGA-meeting-amr-sept2016/en/
2. Antibacterial Agents in Clinical Development: An Analysis of the Antibacterial Clinical Development Pipeline, Including Tuberculosis,2017
3. Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature review
4. Resistance to colistin in Klebsiella pneumoniae: a 4.0 strain?
5. Phage therapy for respiratory infections
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献